|
Consolidated Statements of Operations (USD $)
|
3 Months Ended | |
|---|---|---|
|
Mar. 31, 2015
|
Mar. 31, 2014
|
|
| Revenues | ||
| Revenues | $ 940,172us-gaap_Revenues | $ 903,215us-gaap_Revenues |
| Cost of revenues | 263,914us-gaap_CostOfRevenue | 260,893us-gaap_CostOfRevenue |
| Gross margin | 676,258us-gaap_GrossProfit | 642,322us-gaap_GrossProfit |
| Operating expenses | ||
| General and administrative | 1,161,387us-gaap_GeneralAndAdministrativeExpense | 1,129,953us-gaap_GeneralAndAdministrativeExpense |
| Sales and marketing | 1,092,900us-gaap_SellingAndMarketingExpense | 941,085us-gaap_SellingAndMarketingExpense |
| Engineering, research, and development | 114,144us-gaap_ResearchAndDevelopmentExpense | 297,933us-gaap_ResearchAndDevelopmentExpense |
| Depreciation and amortization | 55,746us-gaap_DepreciationAndAmortization | 68,083us-gaap_DepreciationAndAmortization |
| Total operating expenses | 2,424,177us-gaap_OperatingExpenses | 2,437,054us-gaap_OperatingExpenses |
| Loss from operations | (1,747,919)us-gaap_OperatingIncomeLoss | (1,794,732)us-gaap_OperatingIncomeLoss |
| Other income/(expense) | ||
| Interest income | 56us-gaap_InvestmentIncomeInterest | 1,731us-gaap_InvestmentIncomeInterest |
| Interest expense | (826)us-gaap_InterestExpense | |
| Change in fair value of derivative liabilities | 18,325us-gaap_DerivativeGainLossOnDerivativeNet | 30,079us-gaap_DerivativeGainLossOnDerivativeNet |
| Total other income/(expense) | 18,381us-gaap_NonoperatingIncomeExpense | (30,984)us-gaap_NonoperatingIncomeExpense |
| Loss before income taxes | (1,729,538)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments | (1,763,748)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments |
| Income tax expense | ||
| Net loss | $ (1,729,538)us-gaap_NetIncomeLoss | $ (1,763,748)us-gaap_NetIncomeLoss |
| Net loss per share - basic and diluted | $ (0.08)us-gaap_EarningsPerShareDiluted | $ (0.10)us-gaap_EarningsPerShareDiluted |
| Weighted average number of shares during the period - basic and diluted | 23,022,420us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding | 17,490,954us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding |
| X | ||||||||||
|
- Definition
The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of increase (decrease) in the fair value of derivatives recognized in the income statement. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Sum of operating profit and nonoperating income or expense before Income or Loss from equity method investments, income taxes, extraordinary items, and noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of the cost of borrowed funds accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The net result for the period of deducting operating expenses from operating revenues. No definition available.
|
| X | ||||||||||
|
- Definition
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
|
- Definition
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|